To explore the role of TGF-β/Smad2/3 and NF-κB in the regulation of cell proliferation, we treated SF295, A172 and LN18 glioma cells with TGF-β receptor inhibitor SB431542 and IKKβ inhibitor SC-514. Here, NFKB1 is linked to central nervous system cancer.